Press release
University of Dundee spinout Amphista Therapeutics today announced the delivery of the first discovery milestone under a collaboration and licence agreement with global biopharmaceutical company Bristol Myers Squibb.
Press release
University of Dundee spinout Amphista Therapeutics today announced the delivery of the first discovery milestone under a collaboration and licence agreement with global biopharmaceutical company Bristol Myers Squibb.
Press release
A new University of Dundee spinout opportunity hopes to create vaccines against Strep A as well as novel vaccines for other human and animal diseases, while reducing our reliance on antibiotics.